Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

High intake of saturated fat can promote favorable changes in cardiovascular risk markers (opens in a new tab)

news-medical.net · 2026-10-27

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One claim goes further than the study. 4 other points were not covered by the paper.

  • 2 supported
  • 1 overstated
  • 4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

One claim overstates the study. Two of seven check out. Four claims the study doesn't address.

  • 2 supported
  • 1 overstated
  • 4 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7OverstatedNew analyses from the Norwegian randomized controlled trial CARBFUNC show that more than doubling saturated fat intake over a two-year period can promote favorable changes in several cardiovascular risk markers, without increasing apoB, the main suspected risk factor.View evidenceHide evidence

As statedmore than doubling saturated fat intake over a two-year period

Why this verdict

The abstract-level profile supports that the LCHF arm high in saturated fat had favorable changes in several lipid/lipoprotein markers and no significant apoB increase. However, the headline’s unhedged causal framing that more than doubling saturated fat intake “can promote favorable changes” outruns the secondary-outcome surrogate evidence, especially given high attrition and declining self-reported adherence. The exact 'more than doubling' phrasing and characterization of apoB as the 'main suspected risk factor' are not established in the supplied abstract profile.

1

Study evidence

During months 9–12, the LCHF diet produced significantly greater reductions than A-HCLF and C-HCLF in VLDL particle concentrations, triacylglycerols (TAGs), remnant cholesterol, and the TAG/HDL-C ratio, along with increases in HDL-C, total apoA1, and apoA1 in large HDL particles.

“In a 2-year randomised controlled trial, 193 males and females with obesity were assigned to 1) an acellular carbohydrate-based diet (A-HCLF, comparator arm), 2) a cellular carbohydrate-based diet (C-HCLF), or 3) a low-carbohydrate high-fat (LCHF) diet (75 energy percent fat, thereof 30 SFAs).”
2

Study evidence

Participant attrition increased over time: 74 (39%) at 3 months, 114 (59%) at 6 months, 128 (67%) at 9 months, 135 (70%) at 12 months, and 162 (84%) at 24 months (as reported in abstract).

“Attrition was 74 (39%), 114 (59%), 128 (67%), 135 (70%), and 162 (84%) at 3, 6, 9, 12 and 24 months, respectively.”
Claim 2 of 7Not coveredLDL cholesterol increased by 5-10% on the low-carbohydrate, high-saturated-fat diet, mainly because of larger LDL particles, while small dense LDL particles did not change appreciably.View evidenceHide evidence

As stated5-10%

Why this verdict

The direction and mechanism are supported at abstract level: LDL-C increased on LCHF and was attributed to large LDL particles, with no significant increase in small LDL particles. But the abstract-level profile explicitly lacks numerical effect sizes, so the stated 5–10% LDL-C increase cannot be verified at this evidence depth.

1

Study evidence

During months 9–12, the LCHF diet produced significantly greater reductions than A-HCLF and C-HCLF in VLDL particle concentrations, triacylglycerols (TAGs), remnant cholesterol, and the TAG/HDL-C ratio, along with increases in HDL-C, total apoA1, and apoA1 in large HDL particles.

“In a 2-year randomised controlled trial, 193 males and females with obesity were assigned to 1) an acellular carbohydrate-based diet (A-HCLF, comparator arm), 2) a cellular carbohydrate-based diet (C-HCLF), or 3) a low-carbohydrate high-fat (LCHF) diet (75 energy percent fat, thereof 30 SFAs).”
Claim 3 of 7Not coveredTriglycerides were reduced by as much as 20-35% and HDL cholesterol rose by 5-18% on the high-fat diet, whereas values stayed fairly unchanged on the higher-carbohydrate diets.View evidenceHide evidence

As stated20-35% triglyceride reduction; 5-18% HDL increase

Why this verdict

The abstract-level profile supports greater reductions in TAGs and increases in HDL-C on LCHF compared with higher-carbohydrate arms, with some TAG/VLDL-related differences persisting at 24 months. However, it does not provide the stated numerical ranges of 20–35% triglyceride reduction or 5–18% HDL-C increase, nor does it fully establish that higher-carbohydrate values stayed 'fairly unchanged.'

1

Study evidence

During months 9–12, the LCHF diet produced significantly greater reductions than A-HCLF and C-HCLF in VLDL particle concentrations, triacylglycerols (TAGs), remnant cholesterol, and the TAG/HDL-C ratio, along with increases in HDL-C, total apoA1, and apoA1 in large HDL particles.

“In a 2-year randomised controlled trial, 193 males and females with obesity were assigned to 1) an acellular carbohydrate-based diet (A-HCLF, comparator arm), 2) a cellular carbohydrate-based diet (C-HCLF), or 3) a low-carbohydrate high-fat (LCHF) diet (75 energy percent fat, thereof 30 SFAs).”
Claim 4 of 7Not coveredUsing CT scans at baseline and after 12 months, the researchers found no clear increase in coronary artery calcification on the high-saturated-fat diet and no difference between diet groups in calcification development.View evidenceHide evidence

As stated12 months

Why this verdict

The profile confirms CAC was assessed by CT as a secondary outcome, but the abstract-level profile says no quantitative CAC results, between-arm comparisons, trajectories, or scan-timing details are reported. Therefore the claim of no clear CAC increase and no between-group difference cannot be verified from the supplied abstract-level evidence.

1

Study evidence

Coronary artery calcium (CAC) score by CT imaging is reported as a secondary outcome, but the abstract does not report any quantitative CAC results or between‑arm comparisons.

“As secondary outcomes of the trial, ... coronary artery calcium score by CT imaging.”
Claim 5 of 7Not coveredThe study was published on October 24 in eBioMedicine as a secondary analysis of the CARBFUNC trial.View evidenceHide evidence

As statedOctober 24

Why this verdict

The profile supports that the lipid/lipoprotein findings are secondary outcomes/secondary analyses of CARBFUNC, but the supplied abstract-level profile does not verify the publication date of October 24 or the journal eBioMedicine.

1

Study evidence

During months 9–12, the LCHF diet produced significantly greater reductions than A-HCLF and C-HCLF in VLDL particle concentrations, triacylglycerols (TAGs), remnant cholesterol, and the TAG/HDL-C ratio, along with increases in HDL-C, total apoA1, and apoA1 in large HDL particles.

“In a 2-year randomised controlled trial, 193 males and females with obesity were assigned to 1) an acellular carbohydrate-based diet (A-HCLF, comparator arm), 2) a cellular carbohydrate-based diet (C-HCLF), or 3) a low-carbohydrate high-fat (LCHF) diet (75 energy percent fat, thereof 30 SFAs).”
Claim 6 of 7SupportedThe study included 193 adults with obesity in the area around Bergen in Western Norway and randomly assigned them to three different diets followed for up to two years.View evidenceHide evidence

As stated193 adults

Why this verdict

The profile states that 193 adults with obesity were randomized in the 2-year CARBFUNC trial to three diet arms. The specific geographic phrase 'around Bergen in Western Norway' is not verified in the abstract-level profile, but the central trial-size, population, randomization, diet-arm, and follow-up claims are supported.

1

Study evidence

During months 9–12, the LCHF diet produced significantly greater reductions than A-HCLF and C-HCLF in VLDL particle concentrations, triacylglycerols (TAGs), remnant cholesterol, and the TAG/HDL-C ratio, along with increases in HDL-C, total apoA1, and apoA1 in large HDL particles.

“In a 2-year randomised controlled trial, 193 males and females with obesity were assigned to 1) an acellular carbohydrate-based diet (A-HCLF, comparator arm), 2) a cellular carbohydrate-based diet (C-HCLF), or 3) a low-carbohydrate high-fat (LCHF) diet (75 energy percent fat, thereof 30 SFAs).”
Claim 7 of 7SupportedOne group ate a diet high in total and saturated fat and very low in carbohydrates, while the other two groups ate more standard diets with carbohydrates from either refined or minimally refined sources.View evidenceHide evidence

As statedunder 10 percent of energy from carbohydrates in the high-fat group

Why this verdict

The profile supports the three-arm diet contrast: A-HCLF, C-HCLF, and an LCHF diet with 75% energy from fat and 30% from saturated fatty acids. It also supports that the other two arms were carbohydrate-based. The exact statement that the LCHF group consumed under 10% of energy from carbohydrate is not provided in the abstract-level profile.

1

Study evidence

During months 9–12, the LCHF diet produced significantly greater reductions than A-HCLF and C-HCLF in VLDL particle concentrations, triacylglycerols (TAGs), remnant cholesterol, and the TAG/HDL-C ratio, along with increases in HDL-C, total apoA1, and apoA1 in large HDL particles.

“In a 2-year randomised controlled trial, 193 males and females with obesity were assigned to 1) an acellular carbohydrate-based diet (A-HCLF, comparator arm), 2) a cellular carbohydrate-based diet (C-HCLF), or 3) a low-carbohydrate high-fat (LCHF) diet (75 energy percent fat, thereof 30 SFAs).”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The abstract supports directionally favorable LCHF changes in TAGs/VLDL/remnant cholesterol/HDL-C/apoA1 and an LDL-C increase attributed to large LDL particles without significant apoB or small-LDL increases, but does not provide numerical effect sizes.

    The story reflects the qualitative pattern but presents specific percentage changes for LDL-C, triglycerides, and HDL-C that are not available in the abstract-level profile.

    From 2-year randomized controlled dietary intervention (3-arm)

  • High attrition was reported across follow-up, reaching 84% at 24 months, creating an important limitation for longitudinal interpretation.

    The story caveats mention uncertainty about LDL-C significance and long-term implications, but do not mention the profile’s interpretation-changing attrition concern.

    From trial conduct characterization: retention and self-reported adherence

3 things the story did carry across
  • CARBFUNC was a 2-year randomized controlled dietary intervention in 193 adults with obesity comparing A-HCLF, C-HCLF, and LCHF diets.
  • The main reported biological outcomes were secondary plasma lipid and lipoprotein particle outcomes measured by NMR, not clinical cardiovascular events.
  • The authors’ interpretation is suggestive: lipid/lipoprotein changes may indicate greater lipid turnover and possible CVD-risk implications, but they are not definitive evidence of long-term cardiovascular benefit or safety.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoCompare longitudinal changes in detailed plasma lipid and lipoprotein particle profiles across three diet arms (A-HCLF vs C-HCLF vs LCHF high in saturated fat) as secondary outcomes of the 2-year CARBFUNC randomized controlled trial.2-year randomized controlled dietary intervention (3-arm)Expand

In plain English

Secondary analysis of a 2-year randomized controlled trial (CARBFUNC, n=193 adults with obesity) comparing acellular carbohydrate-based (A-HCLF), cellular carbohydrate-based (C-HCLF), and low-carbohydrate high-fat (LCHF; 75% energy fat, 30% SFA) diets. Plasma lipids and lipoprotein particle subfractions were quantified by NMR spectroscopy at multiple timepoints and analyzed with constrained linear mixed-effects models. Compared with the two higher-carbohydrate diets, the LCHF arm showed larger reductions in VLDL particles, triacylglycerols (TAGs), remnant cholesterol, and the TAG/HDL-C ratio and increases in HDL-C and apoA1 during months 9–12; some TAG- and VLDL-related differences persisted at 24 months, and LCHF increased large LDL particles and LDL-C without significant rises in apoB or small LDLs according to the abstract.

Key findings

  • During months 9–12, the LCHF diet produced significantly greater reductions than A-HCLF and C-HCLF in VLDL particle concentrations, triacylglycerols (TAGs), remnant cholesterol, and the TAG/HDL-C ratio, along with increases in HDL-C, total apoA1, and apoA1 in large HDL particles.
  • Also in the 9–12 month window, LCHF was associated with increased LDL-C attributed to large LDL particles and an increased LDL-C/apolipoprotein B ratio compared with higher-carbohydrate diets.
“In a 2-year randomised controlled trial, 193 males and females with obesity were assigned to 1) an acellular carbohydrate-based diet (A-HCLF, comparator arm), 2) a cellular carbohydrate-based diet (C-HCLF), or 3) a low-carbohydrate high-fat (LCHF) diet (75 energy percent fat, thereof 30 SFAs).”
What this piece can’t prove
  • Adherence was self-reported and declined in the second year (reported 40–60%), which may affect observed long-term differences.
  • Outcomes reported here are secondary trial outcomes according to the abstract; the abstract does not provide full methodological or sensitivity analyses.

3 further details could not be confirmed from the summary.

2human in vivoAssess diet-arm differences over time in coronary artery calcium (CAC) score by CT imaging as a secondary outcome of the CARBFUNC trial.Randomized controlled dietary trial; secondary CT imaging outcome (CAC)Expand

In plain English

The CARBFUNC trial abstract states coronary artery calcium (CAC) score by CT imaging was collected as a secondary outcome in a 3‑arm, 24‑month randomized dietary trial (n=193). The abstract notes the use of constrained linear mixed‑effects modelling for longitudinal analyses but does not report numeric CAC results, comparisons across diet arms, or image acquisition/scoring details.

Key findings

  • Coronary artery calcium (CAC) score by CT imaging is reported as a secondary outcome, but the abstract does not report any quantitative CAC results or between‑arm comparisons.
“As secondary outcomes of the trial, ... coronary artery calcium score by CT imaging.”
What this piece can’t prove
  • Unclear imaging data completeness and whether attrition differentially affected availability of CAC measurements.

2 further details could not be confirmed from the summary.

3human in vivoCharacterize trial implementation features relevant to interpreting metabolic outcomes (attrition over time and self-reported adherence).trial conduct characterization: retention and self-reported adherenceExpand

In plain English

The abstract reports time-varying participant attrition (counts and percentages at 3, 6, 9, 12, and 24 months) and aggregate self-reported dietary adherence ranges (63–85% up to 12 months; 40–60% during the final 12 months). These trial-conduct metrics provide context for missingness and exposure fidelity relevant to interpreting metabolic outcomes but are reported without instrument detail or arm-specific breakdowns in the abstract.

Key findings

  • Participant attrition increased over time: 74 (39%) at 3 months, 114 (59%) at 6 months, 128 (67%) at 9 months, 135 (70%) at 12 months, and 162 (84%) at 24 months (as reported in abstract).
  • Self-reported dietary adherence was reported as 63–85% up to 12 months and 40–60% during the final 12 months (as reported in abstract).
“Attrition was 74 (39%), 114 (59%), 128 (67%), 135 (70%), and 162 (84%) at 3, 6, 9, 12 and 24 months, respectively.”
What this piece can’t prove
  • High overall attrition by 24 months (84%) may reduce effective sample size and introduce bias; abstract gives no missing-data handling strategy.
  • Adherence is presented as broad ranges over periods rather than timepoint-specific or participant-level data, limiting precision of exposure fidelity assessment.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref · 39 candidate papers

And 33 more candidates considered.